Syneos Health   Report issue

Founded: Raleigh NC United States (2018)

Organization Overview

First Clinical Trial
2018
NCT03190824
First Marketed Drug
2020
empagliflozin (jardiance)
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Institution | Syneos Health | Syneos Health, | Syneos Health Inc. | Syneos Health, LLC | Syneos Heath